placeholder image
K. H. Dragnev All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC; SWOG S1507, NCT-02642042). 
    Clinical Cancer Research. 2023
  • Alliance Foundation Trial 09: a randomized, multicenter, phase 2 trial evaluating two sequences of pembrolizumab and standard platinum-based chemotherapy in patients with metastatic NSCLC. 
    JTO Clin Res Rep. 2021
    • Contact
    full name
  • K. H. Dragnev
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration